A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease

This study has been completed.
Cato Research
ClinPharm Consulting, LLC
Infrared Imaging and Thermometry Unit, Biomedical Engineering and Physical Science Shared Resource (NIBIB)
National Chung Cheng University
QS Pharma
Ricerca Biosciences LLC
SAIC-Frederick, Inc.
Information provided by (Responsible Party):
AesRx, LLC
ClinicalTrials.gov Identifier:
First received: April 26, 2012
Last updated: July 1, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)